CYTOKINETICS INC — Director's Dealing 2023

Feb 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-02-06

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-06	Common Stock	M	7000	$6.72	Acquired	19533	Direct
2023-02-06	Common Stock	S	7000	$45.00	Disposed	12533	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-06	Non-Qualified Stock Option (Right to Buy)	$6.72	M	7000	Disposed	2024-01-02	Common Stock (7000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022.